|
Catalogue
Number
|
Product
|
Order number / Unit
|
|
|
9760
|
TETA-Octreotide acetate
|
9760.0001: 1 mg per vial
9760.0010: 10 mg per vial
Please inquire for customized
filling and bulk quantities.
|
|
|
Precursor for radiolabelled TETA-Octreotide
Ligand for somatostatin receptors
|
|
|
|
|
|
|
|
|
Molar Mass: 1433.70
|
|
|
C67H96N14O17S2
|
|
|
[226084-96-4] (net peptide)
|
|
|
|
|
|
Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials.
|
|
|
|
|
|
|
|
|
Purity: ≥ 97 %
|
|
|
Certificates:
CoA; MS (identity) and HPLC (purity)
|
|
|
Chemical Name:
CA index name: L-Cysteinamide, N-[[4,8,11-tris(carboxymethyl)-1,4,8,11-tetraazacyclotetradec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-phenylalanyl- D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
|
|
|
Synonymes:
TETA-Octreotide; TETA-OC
|
|
|
Literature:
1. Anderson C.J. et al. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors. J Nucl Med. 2001, 42, 213-21.
|
|
|
2. Lewis J.S. et al. Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model. Clin Cancer Res. 1999, 5, 3608-16.
|
|
|
3. Anderson C.J. et al. Radiotherapy, toxicity and dosimetry of copper-64-TETA-octreotide in tumor-bearing rats. J Nucl Med. 1998, 39, 1944-51.
|
|
|
|
|
|
|
|
|
date of product catalogue issue:
05 April 2012
|